Where There's Smoke There Must Be Ire! Nicotine Addiction Treatment: a Review
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Tobacco use in the United States has decreased by almost 50 percent since 1965, although the decline over the past few years has stalled. In the high school student population the smoking rates have not only plateaued over the past several years but have even increased. This paper will discuss the pathophysiology of tobacco addiction and treatment options for smoking cessation.
Citing Articles
Water-pipe Tobacco Components and their Association with Oxidative Stress.
Norouzi A, Dehghani T, Eftekhar E Addict Health. 2024; 16(3):205-212.
PMID: 39439856 PMC: 11491865. DOI: 10.34172/ahj.1487.
References
1.
Moal M, Koob G
. Drug addiction: pathways to the disease and pathophysiological perspectives. Eur Neuropsychopharmacol. 2006; 17(6-7):377-93.
DOI: 10.1016/j.euroneuro.2006.10.006.
View
2.
Liechti M, Markou A
. Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies. CNS Drugs. 2008; 22(9):705-24.
DOI: 10.2165/00023210-200822090-00001.
View
3.
Cahill K, Stead L, Lancaster T
. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2007; (1):CD006103.
DOI: 10.1002/14651858.CD006103.pub2.
View
4.
DSouza M, Markou A
. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addict Sci Clin Pract. 2011; 6(1):4-16.
PMC: 3188825.
View
5.
Glassman A, Koob G
. Neuropharmacology. Psychoactive smoke. Nature. 1996; 379(6567):677-8.
DOI: 10.1038/379677a0.
View